THE EFFICACY OF BORTEZOMIB AND BORTEZOMIB-CONTAINING REGIMENS FOR TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL CLINICAL PRACTICE

被引：0
|
作者：
Mitina, T. [1 ]
Golenkov, A. [1 ]
Kataeva, E. [1 ]
Lutskaya, T. [1 ]
Trifonova, E. [1 ]
Klinushkina, E. [1 ]
机构：
[1] MF Vladimirskii Reg Clin Res Inst, Moscow, Russia
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1441
引用
收藏
页码：576 / 576
页数：1
相关论文
共 50 条
  • [1] Tolerability and efficacy of bortezomib containing regimens for the treatment of elderly patients affected by refractory/relapsed multiple myeloma
    Gentile, M.
    Mazzone, C.
    Iorio, C.
    Lucia, E.
    Vigna, E.
    Bisconte, M. G.
    Gentile, C.
    Morabito, F.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 150 - 151
  • [2] Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practice
    Hulin, Cyrille
    de la Rubia, Javier
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Katodritou, Eirini
    Hungria, Vania
    De Samblanx, Hadewijch
    Stoppa, Anne-Marie
    Aagesen, Jesper
    Sargin, Deniz
    Sioni, Anastasia
    Belch, Andrew
    Diels, Joris
    Olie, Robert A.
    Robinson, Don, Jr.
    Potamianou, Anna
    van de Velde, Helgi
    Delforge, Michel
    [J]. HEALTH SCIENCE REPORTS, 2019, 2 (01)
  • [3] Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma in community practice
    Wu, Ka Lung
    van Wieringen, Wessel
    Vellenga, Edo
    Zweegman, Sonja
    Lokhorst, Henk M.
    Sonneveld, Pieter
    [J]. HAEMATOLOGICA, 2005, 90 (07) : 996 - 997
  • [4] EFFECTIVENESS OF BORTEZOMIB AND BORTEZOMIB-CONTAINING PROGRAMS FOR THE TREATMENT OF RECURRENT AND RESISTANT MULTIPLE MYELOMA
    Mitina, T. A.
    Golenkov, A. K.
    Katayeva, E. V.
    Lutskaya, T. D.
    Trifonona, E. V.
    Klinushkina, E. F.
    [J]. TERAPEVTICHESKII ARKHIV, 2010, 82 (07): : 57 - 61
  • [5] Safety and Efficacy of Bortezomib in Refractory/Relapsed Multiple Myeloma
    Lalagianni, C. E.
    Neokleous, N.
    Vadikoliou, C.
    Papalexandri, A.
    Apostolou, C.
    Saloum, R.
    Anagnostopoulos, A.
    Fassas, A.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S26 - S26
  • [6] Bortezomib-containing regimens (BCR) for the treatment of non-transplant eligible multiple myeloma
    Jimenez-Zepeda, Victor H.
    Duggan, Peter
    Neri, Paola
    Tay, Jason
    Bahlis, Nizar J.
    [J]. ANNALS OF HEMATOLOGY, 2017, 96 (03) : 431 - 439
  • [7] Bortezomib-Containing Regimens (BCR) for the Treatment of Non-Transplant Eligible Multiple Myeloma
    Jimenez-Zepeda, Victor H.
    Duggan, Peter
    Neri, Paola
    Bahlis, Nizar J.
    [J]. BLOOD, 2015, 126 (23)
  • [8] The Efficacy and Safety of Bortezomib and Dexamethasone as a Maintenance Therapy in Patients With Advanced Multiple Myeloma Who Are Responsive to Salvage Bortezomib-Containing Regimens
    Benevolo, Giulia
    Larocca, Alessandra
    Gentile, Massimo
    Pregno, Patrizia
    Gay, Francesca
    Botto, Barbara
    Frairia, Chiara
    Evangelista, Andrea
    Morabito, Fortunato
    Boccadoro, Mario
    Vitolo, Umberto
    Palumbo, Antonio
    [J]. CANCER, 2011, 117 (09) : 1884 - 1890
  • [9] Bortezomib-containing regimens (BCR) for the treatment of non-transplant eligible multiple myeloma
    Victor H Jimenez-Zepeda
    Peter Duggan
    Paola Neri
    Jason Tay
    Nizar J Bahlis
    [J]. Annals of Hematology, 2017, 96 : 431 - 439
  • [10] Bortezomib-Containing Regimens for Multiple Myeloma Maintenance Therapy: a Meta-Analysis
    Wang, Yucai
    Zhang, Wenwen
    Yang, Fang
    Guan, Xiaoxiang
    Kothari, Neil
    Chang, Victor
    Wang, Michael
    [J]. BLOOD, 2014, 124 (21)
12345